Imricor Medical Systems, Inc. (IMR.AX)
ASX · AUD · Healthcare · Medical Devices
A$1.30 (-2.26%) as of
Key statistics
- Market cap
- 4.44B
- Forward P/E
- -12.80
- EPS (TTM)
- -0.1600
- Dividend yield
- 0.00%
- 52-week range
- 1.2750 – 2.2500
- Beta
- 0.54
- Revenue (TTM)
- 120.08k
- Profit margin
- 0.00%
- Analyst target
- A$2.95
- Volume
- 351.25k
About Imricor Medical Systems, Inc.
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. The company through its Imricor Cardiovascular vertical provides integrated single session workflows for hospitals for MR imaging. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device's conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Burnsville, MN, United States
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.